Drugs stocks boosted by Clinton defeat
Markets have reacted badly to Trump's electoral victory, but some sectors have benefited
Company
GSK PLC
LON:GSK
GSK PLC will be a fully focused biopharma company following the demerger of its world-leading consumer healthcare business, Haleon, in July 2022. The company will prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease.
746 stories · page 31 of 38
Archive
Brokers: UK pharma giants in good shape if Clinton wins says Citigroup
“From a legislative angle, we continue to prefer names with either limited part D exposure [US Medicare] or heavier contribution of non-pharma assets."
GlaxoSmithKline medicine goes down well in City
Deutsche analyst Richard Parkes said the market beating sales were mainly down to the group's strong sales of vaccines, notably for flu - Bexsero, Boostrix and Synflorix.
FTSE 100 stocks give up 7,000 level as miners come off on copper warning
FTSE 100 stocks gave up the 7,000 level on Wednesday as mining stocks dragged the market lower
Lloyds and a 'hard' Brexit in focus
Investors will be looking for any comment on a potential 'hard' Brexit in the Lloyds statement
US FDA approval for shingles vaccine eyed by Glaxo
The effects of the illness, a reactivation of the latent chickenpox virus, can be excruciating
GSK seeks US green light for shingles vaccine
"Shingles is a common and potentially serious condition,” said GSK’s head of vaccines, Dr Emmanuel Hanon.
Lloyds Banking and RBS to give post-Brexit vote updates
Britain's banks had enough on their plates already, but the Brexit vote made things more complicated still
GSK has been a Brexit winner, but can the FTSE share go higher?
As one of London's big 'dollar earners' it has been on the buy list for investors seeking Brexit winners.
Trending: Ashley's helicopter preference and new GSK boss
Mike Ashley’s interview with the BBC on how he runs Sports Direct this morning got the twittersphere buzzing.
GlaxoSmithKline's choice of new boss disappoints City
Shares fall after drug giant promotes boss of consumer healthcare division to top job
FTSE 100 closes higher, builds on previous day’s gains
UK shares closed higher on Tuesday, extending gains from the previous session, while investors awaited the outcome of central bank meetings in Japan and the United States
GlaxoSmithKline's shingles vaccine lasts four years in elderly patients
In a phase III study published in the New England Journal of Medicine, Shingrix showed a 90% efficacy in adults aged 70 and older that was maintained for four years.
Ocado gets another pasting over margin warning
Exane BNP Paribas downgrades online grocer after it warned of margin pressure from rivals
FTSE 100 closes firm as jobs, commodities buoy stocks
The FTSE 100, London’s blue-chip ticker, closed firm on Wednesday, buoyed by solid jobs data in the wake of Britain’s decision to leave the European Union and a surge by miners on rising commodity prices
UK stocks end lower on falling oil prices, sterling
London stocks end lower on Tuesday, pushed south by falling oil prices and a weaker sterling.
This unfancied drug stock has the potential to soar
There is a huge opportunity for the likes Vectura and is partner Hikma Pharmaceuticals as they copy-cat GlaxoSmithKline's asthma treatment.
GlaxosmithKline hails double drug successes
Drug giant reports upbeat results of lung disease and meningitis drug trials